Home » Topics » Disease categories and therapies » Immune

Immune
RSS

U.K. approval of COVID-19 Vaccine Moderna

Jan. 11, 2021

AstraZeneca's COVID-19 vaccine receives further emergency use authorizations

Jan. 8, 2021

FDA approves IND for phase IIb study of orismilast in patients with plaque psoriasis

Jan. 8, 2021

Topline data presented from phase III KEEPsAKE studies of risankizumab

Jan. 8, 2021

E.U. conditional marketing authorization for Moderna's COVID-19 vaccine

Jan. 7, 2021

New humanized murine model of myelofibrosis shows therapeutic vulnerability

Jan. 4, 2021

T-cell epitope-based COVID-19 vaccine EPV-CoV19 advances towards clinic

Jan. 4, 2021

New humanized graft-versus-host disease mouse model supports NK cell engraftment

Dec. 23, 2020

European Commission approves Palforzia to treat peanut allergy

Dec. 21, 2020

Phase II trials of ALX-629 begin in COVID-19, atopic asthma and psoriasis

Dec. 18, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...